Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor
Donatella Romaniello(Weizmann Institute of Science), Yosef Yarden(Weizmann Institute of Science)
Cited by 60
Related Papers
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization
|Cellular & Molecular Biology Letters|2022|18